Bitcoin Recap: Another Tough Week for US Spot ETFs
US spot Bitcoin ETFs posted a tough week, with persistent outflows until July 2 when buyers returned briefly. Ethereu...
Zero Based Budgeting Strategies For Large Families
This article outlines budgeting strategies for large families, ensuring scalable allocation of funds and clear priorities across many members.
24,021 articles
Michael Burry’s Shorts Going Strong: Is It Too Late to Follow?
Michael Burry’s shorts going strong have produced noticeable gains in select AI-adjacent bets, prompting a timely deb...
Dennis Quaid Lists L.A. Home for $5.2M, Moves to Nashville
Dennis Quaid has listed his Los Angeles residence for $5.2 million as he relocates to Nashville, a move that highligh...
NVIDIA Bears Blind: Reasons to Buy Now Amid AI Boom
NVIDIA faces bearish chatter, yet supporters argue three durable drivers could lift the stock. AI demand, cash return...
Amazon's Stock Historically Cheap: Is Now Your Buy Opportunity
Investors are eyeing a rare moment when amazon's stock historically cheap aligns with a broader growth narrative. Thi...
Broadcom Stock: The Number That Signals a Market Turn Now
Broadcom’s AI chip revenue jumped in Q2 2026, with guidance hinting at even stronger growth ahead. This article break...
Micron Raised Guidance Surging: What It Means for MU
When memory prices surge and Micron raises guidance, MU stock attention swells. This article deciphers the impulse be...
Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Main Reason Behind Buying UnitedHealth Before July 16
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
AAOI Soared 251%, Quietly Doubling Investors’ Money
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
We’re Bullish on Adobe Despite 40% Drop From Peak
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status